BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9555054)

  • 1. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.
    Koppal T; Subramaniam R; Drake J; Prasad MR; Dhillon H; Butterfield DA
    Brain Res; 1998 Mar; 786(1-2):270-3. PubMed ID: 9555054
    [No Abstract]   [Full Text] [Related]  

  • 2. A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
    Butterfield DA; Martin L; Carney JM; Hensley K
    Life Sci; 1996; 58(3):217-28. PubMed ID: 9499162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins.
    Subramaniam R; Roediger F; Jordan B; Mattson MP; Keller JN; Waeg G; Butterfield DA
    J Neurochem; 1997 Sep; 69(3):1161-9. PubMed ID: 9282939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.
    Butterfield DA; Hensley K; Harris M; Mattson M; Carney J
    Biochem Biophys Res Commun; 1994 Apr; 200(2):710-5. PubMed ID: 8179604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
    Subramaniam R; Koppal T; Green M; Yatin S; Jordan B; Drake J; Butterfield DA
    Neurochem Res; 1998 Nov; 23(11):1403-10. PubMed ID: 9814551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.
    Lauderback CM; Hackett JM; Keller JN; Varadarajan S; Szweda L; Kindy M; Markesbery WR; Butterfield DA
    Biochemistry; 2001 Feb; 40(8):2548-54. PubMed ID: 11327877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease.
    Mohmmad Abdul H; Butterfield DA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):140-8. PubMed ID: 15955457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the stabilization of synaptosomes with alpha-tocopherol during activation of lipid peroxidation].
    Davitashvili NG; Erin AN; Prilipko LL
    Biokhimiia; 1986 Mar; 51(3):472-7. PubMed ID: 3697420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
    Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
    Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.
    Walter MF; Mason PE; Mason RP
    Biochem Biophys Res Commun; 1997 Apr; 233(3):760-4. PubMed ID: 9168929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for beta-amyloid aggregation and neurotoxicity based on the free radical generating capacity of the peptide: implications of "molecular shrapnel" for Alzheimer's disease.
    Hensley K; Butterfield DA; Mattson M; Aksenova M; Harris M; Wu JF; Floyd R; Carney J
    Proc West Pharmacol Soc; 1995; 38():113-20. PubMed ID: 7480002
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Arachidonoylglycerol metabolism is differently modulated by oligomeric and fibrillar conformations of amyloid beta in synaptic terminals.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Neuroscience; 2017 Oct; 362():168-180. PubMed ID: 28844762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.
    Butterfield DA; Yatin SM; Varadarajan S; Koppal T
    Methods Enzymol; 1999; 309():746-68. PubMed ID: 10507060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure.
    Hensley K; Carney J; Hall N; Shaw W; Butterfield DA
    Free Radic Biol Med; 1994 Oct; 17(4):321-31. PubMed ID: 8001836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease.
    Butterfield DA; Hensley K; Hall N; Umhauer S; Carney J
    Neurochem Res; 1993 Sep; 18(9):989-94. PubMed ID: 8232727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATR-IR and EPR spectroscopy for following the membrane restoration of isolated cortical synaptosomes in aluminium-induced Alzheimer's disease - Like rat model.
    Ahmed GA; Khalil SKH; Hotaby WE; Abbas L; Farrag ARH; Aal WEA; Sherif HHA; Abdel-Rahman EA; Saber SH; Hassan M; Hassan MH; Balgoon M; Qusti S; Kotb M; Ali SS
    Chem Phys Lipids; 2020 Sep; 231():104931. PubMed ID: 32619464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structural stabilization of lipids and visual pigment rhodopsin in the photoreceptor membrane by vitamin E].
    Tiurin VA; Korol'kov SN; Berman AL; Kagan VE
    Biull Eksp Biol Med; 1987 Oct; 104(10):391-4. PubMed ID: 2823926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease.
    Koppal T; Drake J; Yatin S; Jordan B; Varadarajan S; Bettenhausen L; Butterfield DA
    J Neurochem; 1999 Jan; 72(1):310-7. PubMed ID: 9886083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid.
    Curtain CC; Ali FE; Smith DG; Bush AI; Masters CL; Barnham KJ
    J Biol Chem; 2003 Jan; 278(5):2977-82. PubMed ID: 12435742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.